PGNY Progyny

Progyny, Inc. to Present at Jefferies 2023 Healthcare Conference

Progyny, Inc. to Present at Jefferies 2023 Healthcare Conference

NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies 2023 Healthcare Conference on Wednesday, June 7, 2023, at 2:00 P.M. Eastern Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit

For Further Information, Please Contact:

Investors:

James Hart

Media:

Selena Yang



EN
05/06/2023

Underlying

PGNYProgyny

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE
Free
PGNY PROGYNY

Progyny Appoints Two Renowned Women’s Health Experts to Medical Adviso...

Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board Medical Advisory Board additions support company’s growing product offerings across women’s health and family building NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the appointment of Morehouse School of Medicine’s Regional Dean for Seattle and Puget Sound’s Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fell...

May 14, 2025 1 EN
 PRESS RELEASE
Free
PGNY PROGYNY

Progyny, Inc. to Present at BofA Securities 2025 Health Care Conferenc...

Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 3:00 P.M. Pacific Time / 6:00 P.M. Eastern Time. A live audiocast and replay will be available from the Events and Presentations section of Progyny’s ...

May 12, 2025 1 EN
 PRESS RELEASE
Free
PGNY PROGYNY

Progyny, Inc. Announces First Quarter 2025 Results

Progyny, Inc. Announces First Quarter 2025 Results Reports Record Revenue of $324.0 Million, Reflecting 16.5% GrowthRaises Full Year Guidance Due to Strong Start to the YearEarly Selling Season Activity Reflects Ongoing Demand in Women's Health and Family Building Solutions NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced its financial results for the three-month period ended March 31, 2025 (“the first quarter of 2025”) as compared to the three-month perio...

May 8, 2025 1 EN
 PRESS RELEASE
Free
PGNY PROGYNY

Progyny, Inc. Announces Details for Its First Quarter 2025 Results Rep...

Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building, will report its financial results for the quarterly period ended March 31, 2025, after the close of the market on Thursday, May 8, 2025. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference ...

April 24, 2025 1 EN
 PRESS RELEASE
Free
PGNY PROGYNY

Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating ...

Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer The leadership additions support the company’s continued ability to scale as it delivers the right care model for women’s health and family building NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a global leader in women’s health and family building, today announced the appointments of Melissa Cummings as the company’s first Chief Operating Officer (COO) and Geoffrey Clapp as its first Chief Product Officer (CPO). The additions to the executive ...

April 17, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch